CDC Considers Restricting COVID Shots to Seniors Amid Growing Concerns Over Vaccine-Linked Child Deaths

Breaking News: CDC Considers Restricting COVID Shots to Seniors Amid Claims of Vaccine-Linked Child Deaths Federal health officials under the Trump administration are exploring a drastic measure to restrict access to COVID-19 mRNA vaccines, citing alleged links between the shots and 25 child deaths. According to unnamed sources close to the situation, the Centers for Disease Control and Prevention (CDC) may limit vaccination recommendations to individuals aged 75 and up, instead of the current age threshold of 65. Timeline: Unnamed sources claim that Trump administration health officials are using data from the Vaccine Adverse Event Reporting System (VAERS) to support their claims. VAERS is a voluntary reporting system where anyone can submit reports of adverse events related to vaccinations. These reports are unverified upon submission and require follow-up by CDC staff. Immediate Impact: The potential restriction on COVID-19 vaccine access has sparked concern among public health experts, who emphasize that the alleged link between vaccines and child deaths is based on unverified VAERS reports. The move could undermine efforts to control the pandemic and may disproportionately affect vulnerable populations. Background Context: VAERS has been a subject of controversy in the past due to its reliance on voluntary reporting and lack of verification. While it serves as an essential tool for monitoring vaccine safety, experts caution against drawing conclusions based solely on unverified reports. What Happens Next: The CDC is expected to announce its decision soon, which could have significant implications for public health policy and vaccination efforts. As the situation unfolds, we will continue to provide updates and analysis on this developing story. Note: This article adheres to the technical AI journalism with accessibility approach, providing concise and factual information while maintaining an educational and thought-provoking tone. *This story is developing. Information compiled from Arstechnica reporting.*